Atlas Trials

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Clinical trial NCT06353347 · COMPLETED

Trial details

NCT number
NCT06353347
Sponsor
Shenzhen HighTide Biopharmaceutical Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2023-11-13
Primary completion
2024-12-12
Enrollment
551

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.